Prof. Dr. med. Hartmut Schneider is one of the pioneers of sleep medicine. Already at the beginning of his medical career in 1987 he worked in the field of sleep medicine. He contributed essentially to the establishment of the only academic sleep laboratory at the Philipps University of Marburg at that time, and has since been one of the pioneers of sleep medicine in Europe. His clinical and scientific work is guided by the hypothesis that knowledge of the body’s functions during sleep enables a better knowledge of the patient, and thus better individualized care for the patient. To this end, in parallel with his training as an internist, he has written numerous scientific papers, which earned him international recognition and the Habilitation and Privatdozentur in Internal Medicine in 1999.
After completing his medical training as a specialist in internal medicine at the Philipps University of Marburg in 2000, he was appointed to the most renowned research group in sleep and respiratory medicine, the Johns Hopkins Sleep Disorders Center in Baltimore, USA. There, from 2001 to 2018, he established an internationally recognized reputation as a clinical and scientific expert in the field of sleep and respiratory medicine. Most recently, he was Associate Professor there, in the Department of Pulmonary and Critical Care Medicine and Director of the Bayview Sleep Laboratory at the Sleep Disorders Center at Johns Hopkins University.
Nevertheless, he has remained true to his clinical and scientific focus over the years: In his numerous publications, he has consistently demonstrated that by recording body functions during sleep, better care is provided to patients with COPD, cystic fibrosis and heart disease. To this end, he has developed several new diagnostic and also therapeutic procedures that have become standard in intensive care and sleep medicine today. Furthermore, his sleep medicine attitudes have been implemented in guidelines of the American Thoracic Society and have also been published in several international and national encyclopedias and books. Thus, his academic and clinical influence in the field of sleep and respiratory medicine extends far beyond the German borders.
In 2009, he and his business partner Dr. Riccardo Stoohs founded the American Sleep Clinic in Frankfurt (later called „Center for Sleep Medicine“). In addition to his work as medical director of the Center for Sleep Medicine, he is one of the co-founders of Onera Health and Respimetrix. Since 2016, he has been working as an independent medical-scientific consultant with his company p.s.r. – professional.sleep.research.
Privatdozent für Innere Medizin, UKGM Marburg, German
Associate Professor of Medicine (retired), Johns Hopkins University, Div. Pulm.& Crit.Care Medicine
Education and Training
1980 – 1987 Undergraduate and M.D., Philipps University, Marburg, Germany
1997 -1991 Research Fellow, Sleep Disorders Center of Philipps University, Marburg, Germany
1991 – 2000 Internist, Philipps University, Marburg, (Facharzt Innere Medizin), Recertification 2014
1994 – 1999 Ph.D. Program (Habilitation) of the Philipps University, Marburg, Germany:
1996 – 1999 Pulmonary Fellowship, Johns Hopkins University, Div. Pulm.& Crit.Care Medicine
1987 – 1991 Sleep Research Fellow, Sleep Disorders Center, Philipps University, Marburg, Germany
1999 – present Privatdozent, Division of Pulmonary Medicine, Philipps University, Marburg, Germany
2001 – 2003 Research Associate, Johns Hopkins University, Div. Pulm.& Crit.Care Medicine
2003 – 2005 Instructor of Medicine Johns Hopkins University, Div. Pulm.& Crit.Care Medicine
2006 – 2016 Assistant Professor, Johns Hopkins University, Div. Pulm.& Crit.Care Medicine
2016- present Associate Professor of Medicine, Johns Hopkins University School of Medicine, Baltimore,MD retired since 2019
Awards and Honors
1998 Washington Area Critical Care Society: First Prize, Young Investigator Award (M. Tobin)
2010 Best of Sleep 2010
2015 Highlighted Article from J. Applied Physiol.: Editor’s Choice: Panel discussion
Invited Panels/Study Section
2013 NIH/NHLBI Invited Rev: K99/K22 Review (47 applications) Pathway to Independence
2013 NIH/NHLBI Invited Rev: (24 applications) Special Emphasis Panel: Clinical Trials (HL-14-004)
2014/2015 NIH/NHLBI Invited Reviewer: K99/K22 Review (95 applications) Pathway to Independence
2014 NIH/NHLBI Invited Reviewer. NHLBI SBIR Phase II Review: Point of Care
Publications: 5 Selection of Peer-rev. Original Science Research (> 130 Publ., >3000 Citations, h-index 26)
1. Schneider H, O’Hearn DJ, et al. High-flow transtracheal insufflation treats obstructive sleep apnea: A pilot study. Am J Resp Crit Care Med 161:1869-1876, 2000.
2. Schneider H, SP Patil, et al Hypercapnic duty cycle is an intermediate physiological phenotype linked to mouse chromosome 5. J Appl Physiol; 285: 11-19, 2003.
3. Schneider H, Krishnan V, et al. Inspiratory duty cycle responses to flow limitation predict nocturnal hypoventilation. Eur Respir J. 2009 May; 33(5):1068-76, 2009.
4. Biselli PJ, Kirkness JP, Grote L, Fricke K, Schwartz AR, Smith PL, Schneider H. Nasal High Flow therapy reduces work of breathing compared to oxygen during sleep in COPD and smoking controls – prospective observational study. J Appl Physiol (1985). 2016 Nov 4:jap.00279.2016.
5. Fricke K, Schneider H, et al.: Nasal high flow, but not supplemental O2, reduces peripheral vascular sympathetic activity during sleep in COPD patients Int J Chron Obstruct Pulmon Dis. 2018; 13: 3635–3643.
Grants (5 out of 21)
12/01/16 – 04/30/20 Multicenter Clinical Trial Effect of negative oral pressure on OSA: Somnics: Principal Investigator: Hartmut Schneider, M.D., Ph.D.
12/01/16 – 11/31/17 Clinical Testing of a Home Sleep Apnea Testing (HSAT): Itamar Medical
Principal Investigator: Hartmut Schneider, M.D., Ph.D.
09/14/07 – 08/31/12 NIH SCCOR: Mechanisms and Treatment of COPD Progression
ID number: P50HL074945: Co-Investigator: Hartmut Schneider, M.D., Ph.D.
07/01/11 – 05/31/16 NIH RO1 Grant: Pathogenesis and Outcomes of Sleep Disordered breathing in COPD
HL105546-01: Principal Investigator: Hartmut Schneider, M.D., Ph.D.
07/05/13 – 06/31/16 Sleep-Related Ventilatory Mechanics & Energy Expenditure in Children & Adults with Cystic Fibrosis. ID number: NA_00046790: Principal Investigator: Hartmut Schneider, M.D., Ph.D
Invited Lectures (2 out of 32)
2015 Sleep as an opportunity to prevent respriatory failure: Charite, Berlin.
2016 NIV for Treating Hypercapnic Respiratory Failure: Panel Discussion DGP
European (2) and US Patents (8) awarded:
selection of 2
2013 Schneider H et al.: R Apparatus and method for supplying a respiratory gas: United States Patent 8,522,781
2017 Schneider H, et al: Disposable Sleep and Breathing Monitor: United States Patent 20080092898